William C. Olson, VP, Research & Development at PROGENICS PHARMACEUTICALS INC (PGNX), sold 4,000 shares at $19.03 ($76K) on 2007-12-03, disclosed to the SEC on 2007-12-05.
Scheduled sale ($76k) by VP, Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PGNX | SELL | 2009-06-24 | $12K | — | Filing → |
| PGNX | SELL | 2006-06-22 | $22K | — | Filing → |
| PGNX | SELL | 2006-05-08 | $336K | — | Filing → |